These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Off-label use of stents: bare-metal versus drug-eluting stents. Girod JP; Mulukutla SR; Marroquin OC Expert Rev Cardiovasc Ther; 2008 Sep; 6(8):1095-106. PubMed ID: 18793112 [TBL] [Abstract][Full Text] [Related]
23. Comparison of off-pump coronary artery bypass grafting with percutaneous coronary intervention versus drug-eluting stents for three-vessel coronary artery disease. Yi G; Youn YN; Yoo KJ; Hong YS Ann Thorac Surg; 2008 Nov; 86(5):1438-43. PubMed ID: 19049727 [TBL] [Abstract][Full Text] [Related]
24. Covered stents: a review. Jamshidi P; Mahmoody K; Erne P Int J Cardiol; 2008 Nov; 130(3):310-8. PubMed ID: 18672301 [TBL] [Abstract][Full Text] [Related]
25. Current clinical outcomes of percutaneous coronary intervention and coronary artery bypass grafting. Mack MJ; Prince SL; Herbert M; Brown PP; Katz M; Palmer G; Edgerton JR; Eichhorn E; Magee MJ; Dewey TM Ann Thorac Surg; 2008 Aug; 86(2):496-503; discussion 503. PubMed ID: 18640323 [TBL] [Abstract][Full Text] [Related]
26. Outcomes of bare metal versus drug-eluting stents in allograft vasculopathy. Reddy PR; Gulati A; Steen L; Sinacore J; Leya F; Heroux A J Heart Lung Transplant; 2008 Nov; 27(11):1222-8. PubMed ID: 18971095 [TBL] [Abstract][Full Text] [Related]
27. Drug-eluting stents compared with bare metal stents improve late outcome after saphenous vein graft but not after large native vessel interventions. Jeger RV; Schneiter S; Kaiser C; Bonetti PO; Brunner-La Rocca H; Handke M; Osswald S; Buser PT; Pfisterer ME; Cardiology; 2009; 112(1):49-55. PubMed ID: 18580059 [TBL] [Abstract][Full Text] [Related]
28. Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease. Mehilli J; Kastrati A; Byrne RA; Bruskina O; Iijima R; Schulz S; Pache J; Seyfarth M; Massberg S; Laugwitz KL; Dirschinger J; Schömig A; J Am Coll Cardiol; 2009 May; 53(19):1760-8. PubMed ID: 19422982 [TBL] [Abstract][Full Text] [Related]
29. [Drug-eluting stents for diabetic patients. A critical appraisal of the currently available data from randomized trials]. Silber S; Herdeg C Herz; 2008 Apr; 33(3):196-205. PubMed ID: 18568314 [TBL] [Abstract][Full Text] [Related]
30. Interpreting the music of drug-eluting stents: halcyon song or albatross dirge? Mark DB J Am Coll Cardiol; 2008 May; 51(19):1854-6. PubMed ID: 18466799 [No Abstract] [Full Text] [Related]
31. The challenge of high-risk patients: diabetes and small vessels. Kereiakes D J Invasive Cardiol; 2004 Sep; 16 Suppl F():3F-7F; discussion 18F-21F. PubMed ID: 23573646 [No Abstract] [Full Text] [Related]
32. Cost-effectiveness of the real-world use of drug-eluting stents at 9-month follow-up: results from the Sicilian DES Registry. Tamburino C; Barbagallo R; Capodanno D; di Matteo S; Colombo GL; Recchia M; Ciriminna S; J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):322-9. PubMed ID: 19430343 [TBL] [Abstract][Full Text] [Related]
33. Late stent thrombosis with drug-eluting stents: the price to pay to prevent restenosis? Kumbhani DJ; Bavry AA; Bhatt DL Indian Heart J; 2007; 59(2 Suppl B):B113-7. PubMed ID: 19153427 [TBL] [Abstract][Full Text] [Related]
34. 5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents. Caixeta A; Leon MB; Lansky AJ; Nikolsky E; Aoki J; Moses JW; Schofer J; Morice MC; Schampaert E; Kirtane AJ; Popma JJ; Parise H; Fahy M; Mehran R J Am Coll Cardiol; 2009 Sep; 54(10):894-902. PubMed ID: 19712798 [TBL] [Abstract][Full Text] [Related]
35. Late in-stent restenosis in a patient with drug-eluting stent. Sultan FA; Kazmi K; Dhakam S; Quraishi AU J Coll Physicians Surg Pak; 2005 Oct; 15(10):648-9. PubMed ID: 19810309 [TBL] [Abstract][Full Text] [Related]
36. Mounting evidence for safety and improved outcomes of drug-eluting stenting: but is it the stent? King SB; Hannan EL Circulation; 2008 Oct; 118(18):1783-4. PubMed ID: 18852362 [No Abstract] [Full Text] [Related]
37. Coronary artery stents: Part I. Evolution of percutaneous coronary intervention. Newsome LT; Kutcher MA; Royster RL Anesth Analg; 2008 Aug; 107(2):552-69. PubMed ID: 18633035 [TBL] [Abstract][Full Text] [Related]
38. Comparison of outcomes of drug-eluting stents versus bare-metal stents in nonostial proximal left anterior descending coronary arteries. Bonello L; De Labriolle A; Lemesle G; Roy P; Steinberg DH; Slottow TL; Xue Z; Torguson R; Kaneshige K; Suddath WO; Satler LF; Kent KM; Lindsay J; Pichard AD; Waksman R Am J Cardiol; 2009 Feb; 103(4):496-500. PubMed ID: 19195509 [TBL] [Abstract][Full Text] [Related]
39. 2-year clinical outcomes after implantation of sirolimus-eluting, paclitaxel-eluting, and bare-metal coronary stents: results from the WDHR (Western Denmark Heart Registry). Kaltoft A; Jensen LO; Maeng M; Tilsted HH; Thayssen P; Bøttcher M; Lassen JF; Krusell LR; Rasmussen K; Hansen KN; Pedersen L; Johnsen SP; Sørensen HT; Thuesen L J Am Coll Cardiol; 2009 Feb; 53(8):658-64. PubMed ID: 19232897 [TBL] [Abstract][Full Text] [Related]
40. Percutaneous coronary intervention or coronary artery bypass graft for unprotected left main coronary artery disease: the endless debate. Meliga E; Valgimigli M; Buszman P; Serruys PW J Am Coll Cardiol; 2008 Aug; 52(7):582-4; author reply 584-6. PubMed ID: 18687257 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]